A detailed history of Payden & Rygel Investment Group transactions in Mckesson Corp stock. As of the latest transaction made, Payden & Rygel Investment Group holds 49,200 shares of MCK stock, worth $25.9 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares
49,200
Previous 42,800 14.95%
Holding current value
$25.9 Million
Previous $23 Million 25.06%
% of portfolio
2.32%
Previous 1.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 08, 2024

BUY
$518.81 - $607.81 $3.32 Million - $3.89 Million
6,400 Added 14.95%
49,200 $28.7 Million
Q2 2024

Aug 09, 2024

BUY
$518.81 - $607.81 $3.32 Million - $3.89 Million
6,400 Added 14.95%
49,200 $28.7 Million
Q1 2024

Oct 08, 2024

SELL
$473.42 - $539.26 $3.03 Million - $3.45 Million
-6,400 Reduced 13.01%
42,800 $23 Million
Q1 2024

May 13, 2024

BUY
$473.42 - $539.26 $20.3 Million - $23.1 Million
42,800 New
42,800 $23 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Payden & Rygel Investment Group Portfolio

Follow Payden & Rygel Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel Investment Group with notifications on news.